Development and application of receptor-modified T lymphocytes for adoptive immunotherapy

[1] Generating improved single-chain Fv molecules for tumor targeting [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) : 249 - 260

[2] Altenschmidt U, 1996, CLIN CANCER RES, V2, P1001

[3] Altenschmidt U, 1997, J IMMUNOL, V159, P5509

[4] Alvarez-Vallina L, 1997, J IMMUNOL, V159, P5889

[5] Annenkov AE, 1998, J IMMUNOL, V161, P6604

[6] Crippling of CD3-ζ ITAMs does not impair T cell receptor signaling [J]. IMMUNITY, 1999, 10 (04) : 409 - 420

[7] GENETIC AND MUTATIONAL ANALYSIS OF THE T-CELL ANTIGEN RECEPTOR [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 : 139 - 167

[8] BACH NL, 1994, CELL BIOPHYS, V24-5, P229, DOI 10.1007/BF02789233

[9] The role of T-cell receptor dimerization in T-cell activation [J]. IMMUNOLOGY TODAY, 1999, 20 (12): : 568 - 575

[10] Developments with targeted enzymes in cancer therapy [J]. CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (05) : 579 - 583

[1] Generating improved single-chain Fv molecules for tumor targeting [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 231 (1-2) : 249 - 260

[2] Altenschmidt U, 1996, CLIN CANCER RES, V2, P1001

[3] Altenschmidt U, 1997, J IMMUNOL, V159, P5509

[4] Alvarez-Vallina L, 1997, J IMMUNOL, V159, P5889

[5] Annenkov AE, 1998, J IMMUNOL, V161, P6604

[6] Crippling of CD3-ζ ITAMs does not impair T cell receptor signaling [J]. IMMUNITY, 1999, 10 (04) : 409 - 420

[7] GENETIC AND MUTATIONAL ANALYSIS OF THE T-CELL ANTIGEN RECEPTOR [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 : 139 - 167

[8] BACH NL, 1994, CELL BIOPHYS, V24-5, P229, DOI 10.1007/BF02789233

[9] The role of T-cell receptor dimerization in T-cell activation [J]. IMMUNOLOGY TODAY, 1999, 20 (12): : 568 - 575

[10] Developments with targeted enzymes in cancer therapy [J]. CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (05) : 579 - 583